| Size | Price | Stock |
|---|---|---|
| 1mg | $220 | In-stock |
| 5mg | $570 | In-stock |
| 10mg | $920 | In-stock |
| 25mg | $1850 | In-stock |
| 50 mg | Get quote | |
| 100 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-107126 |
| M.Wt: | 730.03 |
| Formula: | C44H67N5O4 |
| Purity: | >98 % |
| Solubility: | 10 mM in DMSO |
Ibrexafungerp (MK 3118) is an orally active β-1,3-glucan synthesis inhibitor, with potential antifungal activity. Ibrexafungerp can be used for research of Candida and Aspergillus infections[1].
In Vitro: Ibrexafungerp leads to fungicidal activity against various Candida spp., with MIC of 0.5 µg/mL[2].
Ibrexafungerp is effective against C. albicans, C. krusei, C. parapsilosis with MICs of 0.06, 0.5, 0.25 µg/mL[5].
In Vivo: Ibrexafungerp (p.o., 10 mg/kg) is effective against C. auris in an guinea pig cutaneous infection model[4].
Ibrexafungerp (p.o., mouse 1 mg/kg, rat 5 mg/kg and dog 5 mg/kg) exhibits oral bioavailability (mouse 51%, rat 45%, dog 35%)[3].
Ibrexafungerp (i.v., mouse 1 mg/kg, rat 5 mg/kg and dog 5 mg/kg) exhibits moderate half-lives (mouse 5.5, rat 8.7 and, dog 9.3 h) due to high plasma clearance (0.68, 0.44, and 0.45 L/h/kg respectively)[3].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.